229 related articles for article (PubMed ID: 28717006)
1. Extrinsic sialylation is dynamically regulated by systemic triggers
Manhardt CT; Punch PR; Dougher CWL; Lau JTY
J Biol Chem; 2017 Aug; 292(33):13514-13520. PubMed ID: 28717006
[TBL] [Abstract][Full Text] [Related]
2. Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells.
Irons EE; Lau JTY
Front Immunol; 2018; 9():2150. PubMed ID: 30294329
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene.
Jones MB; Nasirikenari M; Lugade AA; Thanavala Y; Lau JT
J Biol Chem; 2012 May; 287(19):15365-70. PubMed ID: 22427662
[TBL] [Abstract][Full Text] [Related]
4. Remodeling of marrow hematopoietic stem and progenitor cells by non-self ST6Gal-1 sialyltransferase.
Nasirikenari M; Veillon L; Collins CC; Azadi P; Lau JTY
J Biol Chem; 2014 Mar; 289(10):7178-7189. PubMed ID: 24425878
[TBL] [Abstract][Full Text] [Related]
5. Protein sialylation by sialyltransferase involves radiation resistance.
Lee M; Lee HJ; Bae S; Lee YS
Mol Cancer Res; 2008 Aug; 6(8):1316-25. PubMed ID: 18708363
[TBL] [Abstract][Full Text] [Related]
6. B-cell-independent sialylation of IgG.
Jones MB; Oswald DM; Joshi S; Whiteheart SW; Orlando R; Cobb BA
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7207-12. PubMed ID: 27303031
[TBL] [Abstract][Full Text] [Related]
7. Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis.
Jones MB; Nasirikenari M; Feng L; Migliore MT; Choi KS; Kazim L; Lau JT
J Biol Chem; 2010 Aug; 285(32):25009-17. PubMed ID: 20529847
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells.
Lee M; Park JJ; Ko YG; Lee YS
Radiat Oncol; 2012 Mar; 7():47. PubMed ID: 22449099
[TBL] [Abstract][Full Text] [Related]
9. Platelets support extracellular sialylation by supplying the sugar donor substrate.
Lee MM; Nasirikenari M; Manhardt CT; Ashline DJ; Hanneman AJ; Reinhold VN; Lau JT
J Biol Chem; 2014 Mar; 289(13):8742-8. PubMed ID: 24550397
[TBL] [Abstract][Full Text] [Related]
10. The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis.
Dougher CWL; Buffone A; Nemeth MJ; Nasirikenari M; Irons EE; Bogner PN; Lau JTY
J Leukoc Biol; 2017 Aug; 102(2):507-516. PubMed ID: 28550122
[TBL] [Abstract][Full Text] [Related]
11. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death.
Amano M; Galvan M; He J; Baum LG
J Biol Chem; 2003 Feb; 278(9):7469-75. PubMed ID: 12499376
[TBL] [Abstract][Full Text] [Related]
12. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
13. IgG sialylation occurs in B cells pre antibody secretion.
Werner A; Hanić M; Zaitseva OO; Lauc G; Lux A; Nitschke L; Nimmerjahn F
Front Immunol; 2024; 15():1402000. PubMed ID: 38827747
[TBL] [Abstract][Full Text] [Related]
14. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
Holdbrooks AT; Britain CM; Bellis SL
J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
[TBL] [Abstract][Full Text] [Related]
15. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
16. Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation.
Lee-Sundlov MM; Ashline DJ; Hanneman AJ; Grozovsky R; Reinhold VN; Hoffmeister KM; Lau JT
Glycobiology; 2017 Jan; 27(2):188-198. PubMed ID: 27798070
[TBL] [Abstract][Full Text] [Related]
17. Alpha-2,6-sialylation regulation in CD34+ progenitor cells in the human bone marrow and granulocyte colony-stimulating factor mobilization.
Hui N; Le Marer N
J Hematother Stem Cell Res; 2001 Oct; 10(5):661-8. PubMed ID: 11672512
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
Dall'Olio F; Chiricolo M; Mariani E; Facchini A
Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
[TBL] [Abstract][Full Text] [Related]
19. Beta-galactoside alpha2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins. A novel regulatory mechanism for alpha2,6-sialylation.
Sugimoto I; Futakawa S; Oka R; Ogawa K; Marth JD; Miyoshi E; Taniguchi N; Hashimoto Y; Kitazume S
J Biol Chem; 2007 Nov; 282(48):34896-903. PubMed ID: 17897958
[TBL] [Abstract][Full Text] [Related]
20. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
Martin LT; Marth JD; Varki A; Varki NM
J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]